| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 0 | 288.388 | 165.691 | 390.066 | 0 | 0 |
| Total Income - EUR | - | - | - | - | 0 | 288.405 | 165.691 | 390.066 | 26 | 0 |
| Total Expenses - EUR | - | - | - | - | 104 | 78.494 | 154.601 | 176.833 | 44.207 | 51.984 |
| Gross Profit/Loss - EUR | - | - | - | - | -104 | 209.911 | 11.090 | 213.232 | -44.180 | -51.984 |
| Net Profit/Loss - EUR | - | - | - | - | -104 | 207.027 | 9.434 | 209.831 | -44.181 | -51.984 |
| Employees | - | - | - | - | 0 | 1 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Medspharm Prod S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 0 | 7.640 | 5.214 | 63.437 | 52.629 |
| Current Assets | - | - | - | - | 4.367 | 219.881 | 195.155 | 343.261 | 103.977 | 61.902 |
| Inventories | - | - | - | - | 4.011 | 2.730 | 11.537 | 29.556 | 11.966 | 14.061 |
| Receivables | - | - | - | - | 17 | 164.626 | 179.553 | 221.227 | 18.619 | 20.623 |
| Cash | - | - | - | - | 338 | 52.525 | 4.066 | 92.478 | 73.392 | 27.219 |
| Shareholders Funds | - | - | - | - | -62 | 206.973 | 199.687 | 209.872 | 165.055 | 112.148 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 4.428 | 12.908 | 4.854 | 138.603 | 2.359 | 2.383 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Medspharm Prod S.r.l.